Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,303 papers from all fields of science
Search
Sign In
Create Free Account
4-(4-hydroxybenzoyl)phenylalanine
Known as:
4-HB-Phe
, p-(4-hydroxybenzoyl)phenylalanine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Phenylalanine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A high-affinity, radioiodinatable neuropeptide FF analogue incorporating a photolabile p-(4-hydroxybenzoyl)phenylalanine.
Lauriane Bray
,
L. Moulédous
,
J. Tafani
,
M. Germanier
,
J. Zajac
Analytical Biochemistry
2014
Corpus ID: 32374135
2008
2008
p-(4-Hydroxybenzoyl)Phenylalanine
S. J. Enna
,
D. Bylund
2008
Corpus ID: 209156143
2006
2006
Molecular Approximation between Residue 10 of Secretin and Its Receptor Demonstrated by Photoaffinity Labeling
M. Dong
,
L. Miller
Annals of the New York Academy of Sciences
2006
Corpus ID: 34192505
Abstract: Using photoaffinity labeling, we have previously explored the molecular approximations between multiple positions of…
Expand
2002
2002
Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10
M. Dong
,
D. Pinon
,
L. Miller
Regulatory Peptides
2002
Corpus ID: 21404525
1997
1997
p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analog amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor.
C. Wilson
,
S. Husain
,
E. R. Stimson
,
L. Dangott
,
K. Miller
,
J. Maggio
Biochemistry
1997
Corpus ID: 13288430
Benzoylphenylalanine, a photoreactive phenylalanine analog that can be incorporated into a peptide during solid-phase synthesis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE